Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / CALL
-
Number of holders
-
0
-
Price
-
$94.68
Significant Holders of VERTEX PHARMACEUTICALS INC - CALL as of Q2 2014
9 filings reported holding 92532F900 - VERTEX PHARMACEUTICALS INC - CALL as of Q2 2014.
VERTEX PHARMACEUTICALS INC - CALL has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of shares
.
Largest 10 shareholders include Citadel Advisors LLC (149,800 shares), GROUP ONE TRADING, L.P. (110,300 shares), Iguana Healthcare Management, LLC (35,000 shares), COMMERZBANK AKTIENGESELLSCHAFT /FI (30,000 shares), SABBY MANAGEMENT, LLC (29,836 shares), Timber Hill LLC (25,200 shares), KCG Holdings, Inc. (17,500 shares), Focused Wealth Management, Inc (12 shares), Ghost Tree Capital, LLC (0 shares), and SPHERA FUNDS MANAGEMENT LTD. (1,000 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.